Document Detail


Rectal administration of d-alpha tocopherol for active ulcerative colitis: a preliminary report.
MedLine Citation:
PMID:  18932276     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To investigate the anti-oxidant and anti-neutrophil recruitment effects of rectal d-alpha (d-alpha) tocopherol administration on mild and moderately active ulcerative colitis (UC). METHODS: Fifteen patients with mild and moderately active ulcerative colitis were enrolled in an open-label study of d-alpha tocopherol enema (8000 U/d) for 12 wk. All patients were receiving concomitant therapy with 5-aminosalicylic acid derivatives (5-ASA) and/or immunomodulator medications. Endoscopic evaluation was performed at baseline and after 4th and 12th weeks. Disease activity was measured with the Mayo disease activity index (DAI) and remission was defined as DAI of < or = 2 with no blood in stool. Clinical response was defined as a DAI reduction of > or = 2. RESULTS: At the end of 12th week, the average DAI score significantly decreased compared to the beginning of the study (2.3 +/- 0.37 vs 8 +/- 0.48, P < 0.0001). One patient was withdrawn after 3 wk for being unavailable to follow-up. On the 4th week of therapy, 12 patients showed clinical response, 3 of whom (21.4%) achieving remission. After 12 wk, all 14 patients responded clinically to the therapy and remission was induced in 9 of them (64%). No patient reported adverse events or was hospitalized due to worsened disease activity. CONCLUSION: This preliminary report suggests that rectal d-alpha tocopherol may represent a novel therapy for mild and moderately active UC. The observed results might be due to the anti-inflammatory and anti-oxidative properties of vitamin E.
Authors:
Seyed-Amir Mirbagheri; Behtash-Ghazi Nezami; Solmaz Assa; Mannan Hajimahmoodi
Related Documents :
23282296 - Preoperative characteristics and functional outcomes of lower limb amputees treated at ...
4435586 - Gastric acid secretion and risk of recurrence of duodenal ulcer within six to eight yea...
9398896 - Helicobacter pylori-positive duodenal ulcer: a long-term double-blind randomized study ...
11579646 - Use of topical ketanserin for the treatment of ulcers in leprosy patients.
21924636 - Tranexamic acid reduces blood transfusions in elderly patients undergoing combined aort...
23365056 - α-synuclein pathology is related to postoperative delirium in patients undergoing gast...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  14     ISSN:  1007-9327     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-10-20     Completed Date:  2009-02-12     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  5990-5     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Amir-Alam Hospital, Tehran 13145-784, Iran. mirbagherimd@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Rectal
Adult
Antioxidants / administration & dosage*,  adverse effects
Colitis, Ulcerative / drug therapy*
Dose-Response Relationship, Drug
Enema
Female
Humans
Male
Middle Aged
Severity of Illness Index
Treatment Outcome
alpha-Tocopherol / administration & dosage*,  adverse effects
Chemical
Reg. No./Substance:
0/Antioxidants; 59-02-9/alpha-Tocopherol
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-...
Next Document:  Dietary glycine blunts liver injury after bile duct ligation in rats.